Tag Archives: United States Patent and Trademark Office

BIO Press Release: BIO and AUTM file Amicus Brief in Myriad Case

The Biotechnology Industry Organization (BIO) filed an amicus brief in the U.S. Court of Appeals for the Federal Circuit on Friday, October 29th, in an appeal of a lawsuit brought by the American Civil Liberties Union on behalf of a number of plaintiffs against Myriad Genetics, the U.S. Patent and Trademark Office, and others. The brief, filed jointly with the Association of University Technology Managers (AUTM), supports the patentability of isolated DNA molecules, noting that Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , ,

USPTO Requesting Comments on Humanitarian Technologies

In case you missed it, on September 20 the United States Patent Office issued a request for comments on incentivizing humanitarian technologies and licensing through the intellectual property system.  The USPTO is trying to incentivize humanitarian technologies by creating a “fast-track ex parte reexamination voucher pilot program.”  The program will give priority to humanitarian technology patents shortening the review process to six months.  The USPTO also hopes the program will reduce costs for humanitarian technology Read More >

Patently BIOtech  |  2 Comments  |  Email This Post
Tags: , , , , , , , , , , , , ,

BIO Commends Supreme Court for Expansive View of Patentability in Bilski Decision

The Biotechnology Industry Organization (BIO) released the following statement in reaction to the Supreme Court’s decision to uphold the lower court’s ruling in Bilski v. Kappos.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

IPWatchdog Blog: “In Search of Technology Transfer Best Practices”

The BIO-AUTM Technology Transfer Symposium panel on The Role of Universities, Biotechnology Companies and Technology Transfer in the Innovation Economy included an active debate on issues ranging from increasing the odds for a successful partnership and the pros and cons of the Bayh-Dole Act.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Policy Leaders Discuss U.S. Innovation Economy at BIO-AUTM Technology Transfer Symposium

Today’s Technology Transfer Symposium’s panel on The Role of Universities, Biotechnology Companies and Technology Transfer in the Innovation Economy included an active debate on issues ranging from increasing the odds for a successful partnership and the pros and cons of the Bayh-Dole Act.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,